These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2314351

  • 1. [Acral skin circulation following intra-arterial infusion of vasodilating substances in patients with intermittent claudication].
    Scheffler A, Rieger H.
    Med Klin (Munich); 1990 Jan 15; 85(1):1-5. PubMed ID: 2314351
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin therapy of peripheral occlusive arterial disease.
    Linhart J.
    Sb Lek; 1998 Jan 15; 99(4):355-62. PubMed ID: 10803275
    [Abstract] [Full Text] [Related]

  • 3. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P, Maurel A.
    Angiology; 1998 Feb 15; 49(2):105-14. PubMed ID: 9482510
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989 Feb 15; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

  • 5. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
    Rudofsky G.
    Wien Klin Wochenschr; 1988 Jul 15; 100(14):484-8. PubMed ID: 3062906
    [Abstract] [Full Text] [Related]

  • 6. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER, Klugherz B, Goldman R, Kimmel SE, Wade M, Sehgal CM.
    Vasc Med; 2000 Jul 15; 5(4):231-7. PubMed ID: 11213235
    [Abstract] [Full Text] [Related]

  • 7. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
    Creutzig A, Caspary L, Radeke U, Specht S, Ranke C, Alexander K.
    Med Klin (Munich); 1988 Jun 17; 83(13-14):434-8. PubMed ID: 3062344
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T, Eckstein H, Weiss C, Diehm C.
    Vasc Med; 1998 Jun 17; 3(3):171-5. PubMed ID: 9892509
    [Abstract] [Full Text] [Related]

  • 10. Improvement of microcirculation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1.
    Heider P, Wildgruber M, Wolf O, Schuster T, Lutzenberger W, Berger H, Eckstein HH.
    Prostaglandins Other Lipid Mediat; 2009 Jan 17; 88(1-2):23-30. PubMed ID: 18832042
    [Abstract] [Full Text] [Related]

  • 11. [Circadian variations of cutaneous blood flow in normal subjects and in patients with peripheral arteriopathies. Effect of PGE1 and alpha-cyclodextrin].
    Laurora G, Belcaro G.
    Minerva Cardioangiol; 1998 Oct 17; 46(10 Suppl 1):45-9. PubMed ID: 10658444
    [Abstract] [Full Text] [Related]

  • 12. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M, Hülsmann M, Berger R, Rödler S, Frey B, Stanek B, Pacher R.
    Wien Klin Wochenschr; 1998 Jul 31; 110(13-14):473-8. PubMed ID: 9746960
    [Abstract] [Full Text] [Related]

  • 13. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution.
    Lynch TG, Hobson RW, Barbalinardo JP, Kerr JC.
    Surgery; 1984 Jul 31; 96(1):35-41. PubMed ID: 6539953
    [Abstract] [Full Text] [Related]

  • 14. Effects of intravenous lipoprostaglandin E1 on neurogenic intermittent claudication.
    Murakami M, Takahashi K, Sekikawa T, Yasuhara K, Yamagata M, Moriya H.
    J Spinal Disord; 1997 Dec 31; 10(6):499-504. PubMed ID: 9438815
    [Abstract] [Full Text] [Related]

  • 15. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil].
    Dorigo B, Raspanti D, Trapani M, Albanese B, Cameli AM, Digiesi V.
    Minerva Med; 1985 Feb 25; 76(7):269-75. PubMed ID: 3974940
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological vasodilation during reconstructive vascular surgery.
    Sonnenfeld T, Cronestrand R.
    Acta Chir Scand; 1980 Feb 25; 146(1):9-14. PubMed ID: 6103626
    [Abstract] [Full Text] [Related]

  • 17. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K, Ikeda U, Murakami Y, Yoshioka T, Shimada K.
    Am Heart J; 2003 Feb 25; 145(2):330-3. PubMed ID: 12595852
    [Abstract] [Full Text] [Related]

  • 18. Effect of prostaglandin E1 on blood flow in normal and ischemic canine hindlimbs.
    Pasch AR, Ricotta JJ, Burke AR, O'Mara RE, DeWeese JA, Wilson G.
    Surgery; 1984 Jun 25; 95(6):724-9. PubMed ID: 6539509
    [Abstract] [Full Text] [Related]

  • 19. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates].
    Creutzig A, Caspary L, Radeke U, Specht S, Alexander K.
    Vasa Suppl; 1988 Jun 25; 23():133-5. PubMed ID: 3061036
    [No Abstract] [Full Text] [Related]

  • 20. The effects of prostaglandin E-1 in patients with intermittent claudication.
    Milio G, Coppola G, Novo S.
    Cardiovasc Hematol Disord Drug Targets; 2006 Jun 25; 6(2):71-6. PubMed ID: 16787192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.